FAQs
Vera Bradley Foundation fundraising events are more meaningful when the hosts and guests have a true understanding of what they are contributing to. Watch and share the latest Vera Bradley Foundation video for an easy way to communicate the message and inspire everyone involved.
What is the Foundation's mission?
“The Foundation is dedicated to raising funds to end breast cancer in our lifetime.”
How does Vera Bradley support the Foundation?
When you purchase designs in Vera Bradley breast cancer awareness colors, you show your support for breast cancer research. Vera Bradley is dedicated to eradicating breast cancer as a life-threatening disease. Since 1993, Vera Bradley has supported breast cancer research through generous contributions of money and other resources to the Vera Bradley Foundation for Breast Cancer.
In addition to Vera Bradley’s support, where does the money come from?
Foundation events, combined with corporate and individual contributions, are the cornerstone of our fundraising. Donations from the Foundation often help kick-start critical research projects at the Vera Bradley Foundation Center for Breast Cancer Research. With our initial support, new research can gain merit and eventually, larger grants. On average, $1 million in donations made by the Foundation have multiplied tenfold.
In addition to individual donations, dedicated friends, Vera Bradley retailers and other committed partners nationwide host their own events in a variety of ways to invite more contributors to help.
What does the Vera Bradley Foundation fund?
The Vera Bradley Foundation is a 501(c)(3) non-profit fundraising organization based in Fort Wayne, Indiana, at the Vera Bradley headquarters.
Our team at the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine collaborates with researchers and leads clinical trials nationwide.
They are focused on developing and dramatically improving therapies for some of the most difficult-to-treat types of breast cancer, including triple negative breast cancer. Their progress on Monogrammed Medicine is leading to promising discoveries in the areas of diagnosis and personalized treatment. Our researchers are also focused on prevention, investigating how healthy cells become cancerous — information that will help women
make better, more informed decisions about prevention choices.